Date recorded: June 15 2021
Identifying the relevant analytical methods to characterize adeno-associated viruses (AAVs) helps gene therapy developers determine product stability during formulation development. This provides a strong foundation for robust products and simplified distribution.
Join us to learn as Carina Rodenstein, Scientist at Leukocare, compares the analytical techniques used to study features of viral vectors that are crucial to capsid design and formulation development. Formulation development requires optimal resolution of analytics to investigate the stability-indicating parameters of viruses under different stresses. Based on the example of a non-enveloped AAV, Carina will demonstrate how to define relevant analytical methods for your specific needs.
In addition to the learning outcomes listed below, there will also be a Q+A session where you’ll be able to hear Carina answer questions asked by the audience.